Marshall Wace
PRCT icon

Marshall Wace’s Procept Biorobotics PRCT Stock Holding History

Marshall Wace’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.71M Sell
297,159
-401,073
-57% -$10M 0.01% 1224
2026
Q1 		$17.5M Buy
698,232
+480,790
+221% +$13.5M 0.02% 757
2025
Q4 		$6.84M Sell
217,442
-164,092
-43% -$5.44M 0.01% 1020
2025
Q3 		$13.6M Buy
381,534
+377,387
+9,100% +$17.2M 0.01% 808
2025
Q2 		$239K Sell
4,147
-110,675
-96% -$6.26M ﹤0.01% 2404
2025
Q1 		$6.69M Buy
114,822
+105,894
+1,186% +$7.23M 0.01% 935
2024
Q4 		$719K Sell
8,928
-6,224
-41% -$532K ﹤0.01% 1885
2024
Q3 		$1.21M Buy
15,152
+5,869
+63% +$417K ﹤0.01% 1568
2024
Q2 		$567K Buy
+9,283
New +$552K ﹤0.01% 1916
2023
Q3 		– Sell
-17,100
Closed -$604K – 2573
2023
Q2 		$604K Buy
+17,100
New +$565K ﹤0.01% 1915
2023
Q1 		– Sell
-12,579
Closed -$523K – 3013
2022
Q4 		$523K Sell
12,579
-45,001
-78% -$1.93M ﹤0.01% 2353
2022
Q3 		$2.39M Buy
57,580
+48,037
+503% +$1.92M 0.01% 1895
2022
Q2 		$313K Buy
+9,543
New +$347K ﹤0.01% 3011
2022
Q1 		– Sell
-116,493
Closed -$2.91M – 3880
2021
Q4 		$2.91M Buy
+116,493
New +$4.31M 0.01% 1807

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Marshall Wace's PRCT Position: Q2 2026 in Review

Marshall Wace reduced its Procept Biorobotics (PRCT) stake by 57% in Q2 2026, selling an estimated $10M and leaving 297,159 shares worth $6.71M. The position accounts for 0.01% of the portfolio, ranked #1224.

Marshall Wace first reported a position in PRCT in Q4 2021 and has held it in 14 quarters since. The position peaked at $17.5M in Q1 2026. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Marshall Wace held 297,159 shares of Procept Biorobotics worth $6.71M as of Q2 2026.
  • Marshall Wace sold 401,073 Procept Biorobotics shares in Q2 2026, an estimated $10M.
  • Procept Biorobotics made up 0.01% of Marshall Wace's portfolio in Q2 2026, its #1224 holding.
  • Marshall Wace first reported a position in Procept Biorobotics in Q4 2021 and has held it in 14 quarters since.
  • Marshall Wace's Procept Biorobotics position peaked at $17.5M in Q1 2026.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.